Cappella, a medical device company developing solutions for the treatment of coronary bifurcation disease, has appointed Eamonn Hobbs to the role of chairman of the board of directors, effective immediately.
Mr Hobbs is president, CEO and director of Delcath Systems and was previously, president and CEO of AngioDynamics, which he co-founded.
Cappella said that Mr Hobbs is an entrepreneurial senior executive with over 30 years of medical device experience and demonstrated success in growing profitable medical device businesses.
Mr Hobbs joined Cappella’s board of directors early this year and moves into the chairman position, previously held by Wolfgang Oster, managing partner at PolyTechnos Venture-Partners, who will remain a director.
Mr Hobbs said: “This is an exciting time for Cappella. Cappella is extremely well-positioned to grow its business and take the pole position in the emerging bifurcation market.
“I am impressed by the achievements of Cappella’s worldclass development team with Art Rosenthal at its helm and look forward to help transform this new medical practice which is now available to interventional cardiologists and their patients into a commercially highly successful company.”
Dr Oster said: “The company has arrived at a juncture which warrants emphasis on commercial objectives and I am certain that Eamonn’s strength and vision will create an eminent position for our technology in the market place.